비교리스트

 카트 문의
시장보고서
상품코드
1404774

세포 분리 시장 규모, 점유율, 동향 분석 보고서 : 기술별, 세포 유형별, 용도별, 제품별, 최종 용도별, 부문별 예측(2024-2030년)

Cell Separation Market Size, Share & Trends Analysis Report By Technique (Surface Marker, Filtration), By Cell Type (Human, Animal), By Application (Cancer Research, Stem Cell Research), By Product, By End-use, And Segment Forecasts, 2024 - 2030
발행일: | 리서치사: Grand View Research | 페이지 정보: 영문 200 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세포 분리 시장 성장 및 동향:

세계 세포 분리 시장 규모는 2030년까지 174억 3,000만 달러에 달할 것으로 예상되며, 예측 기간 동안 9.94%의 CAGR을 기록할 것으로 예상됩니다.

재조합 치료용 단백질과 같은 바이오의약품에 대한 수요 증가가 시장 성장을 견인할 것으로 예상됩니다. 주요 기업들은 연구자 및 의료 전문가들의 요구를 충족시키기 위해 첨단 제품 개발 및 상용화에 주력하고 있으며, 이는 가까운 장래에 세포 분리 제품에 대한 수요를 촉진할 것으로 예상됩니다. 근위축성 측삭경화증, 파킨슨병, 척수 손상과 같은 신경 질환, 신장, 골격, 다발성 경화증, 제1형 당뇨병, 크론병과 같은 자가면역 질환과 같은 널리 알려진 질병을 치료하기 위해 세포 치료의 사용이 증가하고 있습니다.

최근 몇 년 동안 암 및 기타 만성 질환을 치료하고 관리하는 데 도움이 되기 때문에 세포 기반 연구에 대한 정부 기관의 자금 지원이 증가하고 있습니다. 팬데믹 기간 동안 세계 시장은 더욱 탄력을 받았습니다. 예를 들어, 2020년 시애틀 어린이 연구소(Seattle Children's Research Institute) 연구진은 유세포 분석(IP-FCM) 검사를 통한 면역 침강법을 사용하여 COVID-19 감염 환자의 면역 반응을 조사했습니다. 실험에 따르면, 24명의 COVID-19 양성 환자에서 혈액 샘플을 채취하여 30명의 건강한 사람의 혈액 샘플과 비교하고, 비교된 샘플을 IP-FCM 검사에 적용했습니다. 또한, 투자 및 정부 자금의 증가로 인해 세포 분리 및 바이오의약품 제조를 위한 기술적으로 진보된 공정의 가용성이 증가하고 있습니다. 이러한 발전은 세포 분리 방법에 대한 수요 증가로 이어져 시장 성장을 촉진하고 있습니다.

세포 분리 시장 보고서 하이라이트

  • 소모품 제품 유형 부문은 2023년 61.94%의 주요 수익 점유율을 차지했습니다. 바이오 제약 및 생명공학 기업의 R&D 투자 증가가 이 부문의 성장을 이끄는 주요 요인입니다.
  • 생체 분자 분리 응용 분야는 암, HIV 및 기타 자가 면역 질환 연구에 있어 매우 중요한 단계이기 때문에 2023년 29.5%의 가장 큰 점유율을 차지했습니다.
  • 인간 세포 유형 부문은 예측 기간 동안 12.47%의 높은 성장률을 기록할 것으로 예상됩니다. 이러한 급격한 성장은 인간 및 암 줄기세포 연구에 대한 관심이 높아지고 분리된 인간 세포의 다양한 적용에 기인합니다.
  • 원심분리 기술 유형 부문은 2023년 42.3%의 가장 높은 시장 점유율을 차지했습니다. 다양한 원심분리기를 사용할 수 있기 때문에 기술자는 특정 요구에 맞는 다양한 선택을 할 수 있습니다.
  • 북미는 2023년 39.8%의 매출 점유율로 세계 시장을 장악했는데, 이는 신기술에 대한 수요 증가, 주요 기업의 대규모 풀, 백신 및 치료제 개발 증가, 첨단 의료 인프라에 기인합니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 세포 분리 시장 변수, 동향, 범위

  • 시장 계통 전망
    • 상부 시장 전망
    • 부수 시장 전망
  • 시장 동향과 전망
  • 시장 역학
    • 시장 성장 촉진요인 분석
    • 시장 성장 억제요인 분석
    • 시장 기회 분석
    • 시장 과제 분석
  • 세포 분리 시장 분석 툴
    • SWOT 분석 : 요인별(정치·법률, 경제, 기술)
    • Porter's Five Forces 분석
    • COVID-19의 영향 분석

제4장 제품 비지니스 분석

  • 세포 분리 시장 : 제품 변동 분석
  • 소모품
  • 기기

제5장세 유형 비지니스 분석

  • 세포 분리 시장 : 세포 유형 변동 분석
  • 인간 세포
  • 동물 세포

제6장 기술 비지니스 분석

  • 세포 분리 시장 : 기술 변동 분석
  • 원심분리
  • 표면 마커
  • 여과

제7장 용도 비지니스 분석

  • 세포 분리 시장 : 용도 변동 분석
  • 생체 분자 분리
  • 암 연구
  • 줄기세포 연구
  • 조직 재생
  • 체외진단
  • 치료제

제8장 최종 용도 비지니스 분석

  • 세포 분리 시장 : 최종 용도 변동 분석
  • 조사·연구기관
  • 병원 및 진단 연구소
  • 세포은행
  • 바이오테크놀러지 및 바이오의약품 기업

제9장 지역 비지니스 분석

  • 지역별 세포 분리 시장 점유율(2023년·2030년)
    • 북미
    • 유럽
    • 아시아태평양
    • 라틴아메리카
    • 중동 및 아프리카

제10장 기업 개요

  • 기업 개요
    • THERMO FISHER SCIENTIFIC, INC
    • MERCK KGAA
    • BD
    • TERUMO CORPORATION
    • DANAHER
    • STEMCELL TECHNOLOGIES INC.
    • BIO-RAD LABORATORIES, INC.
    • AGILENT TECHNOLOGIES, INC.,
    • CORNING INCORPORATED.
    • AKADEUM LIFE SCIENCES
ksm 24.01.18

Cell Separation Market Growth & Trends:

The global cell separation market size is expected to reach USD 17.43 billion by 2030, registering a CAGR of 9.94% over the forecast period, according to a new report by Grand View Research, Inc. The increasing demand for biopharmaceuticals, such as recombinant therapeutic proteins, is anticipated to boost market growth. The key players focus on the development & commercialization of advanced products to cater to the needs of researchers and healthcare professionals, which is projected to drive the demand for cell isolation products in the near future.The usage of cellular therapies is increasing for the treatment of prominent diseases, including neurological diseases, such as amyotrophic lateral sclerosis, Parkinson's disease, spinal cord injury, and renal, skeletal, & autoimmune diseases, such as multiple sclerosis, type 1 diabetes, & Crohn's disease.

In recent years, there has been an increase in funding from government organizations for cell-based research owing to its ability to treat & manage conditions, such as cancer and other chronic diseases. The global market witnessed an upward momentum during the pandemic. For instance, in 2020, Seattle Children's Research Institute's researchers used immunoprecipitation, identified by flow cytometry (IP-FCM) test, to study the immune response of COVID-19-infected patients. As per the experiment, blood samples were collected from 24 COVID-19-positive patients to compare with blood samples of 30 healthy individuals, and the compared samples were run through the IP-FCM test.Furthermore, increasing investments and government funding have helped boost the availability of technologically advanced processes for cell isolation & biopharmaceutical production. These advancements have resulted in an increased demand for cell separation procedures, thus propelling the market growth.

Cell Separation Market Report Highlights:

  • The consumables product type segment held a major revenue share of 61.94% in 2023. The increasing investments in R&D by biopharmaceutical and biotech companies are a major factor propelling the segment growth
  • The biomolecule isolation application segment held the largest share of 29.5% in 2023 since it is a pivotal step in research on cancer, HIV, and other autoimmune diseases
  • The human cell type segment is anticipated to have a significant growth rate of 12.47% during the forecast period. The fast growth is due to the rising focus on human and cancer stem cell research and varied applications of isolated human cells
  • The centrifugation technique type segment held the highest market share of 42.3% in 2023. The availability of various centrifuges provides technicians with a wide range of options catering to their specific needs
  • North America dominated the global market with a revenue share of 39.8% in 2023 owing to increasing demand for new technologies, a large pool of key players, increasing development of vaccines and therapeutics, along with advanced healthcare infrastructure

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Information analysis
    • 1.2.2. Market formulation & data visualization
    • 1.2.3. Data validation & publishing
  • 1.3. Research Assumptions
  • 1.4. Information Procurement
    • 1.4.1. Primary Research
  • 1.5. Information or Data Analysis
  • 1.6. Market Formulation & Validation
  • 1.7. Market Model
  • 1.8. Global Market: CAGR Calculation
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Cell Separation Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
      • 3.3.1.1 Rising demand for biopharmaceuticals
      • 3.3.1.2 Increasing government funding for cell-based research
      • 3.3.1.3 Growing focus on personalized medicine
    • 3.3.2. Market Restraint Analysis
      • 3.3.2.1. High cost of cell isolation products
    • 3.3.3. Market Opportunities Analysis
      • 3.3.3.1. Growth in biopharmaceutical outsourcing industry
      • 3.3.3.2. Developing countries provide untapped markets for multinational players
    • 3.3.4. Market Challenges Analysis
      • 3.3.4.1. Stringent Regulatory Frameworks and Time-Consuming Approval Processes for Cell Isolation/Separation
  • 3.4. Cell Separation Market Analysis Tools
    • 3.4.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
    • 3.4.2. Porter's Five Forces Analysis
    • 3.4.3. COVID-19 Impact Analysis

Chapter 4. Product Business Analysis

  • 4.1. Cell Separation Market: Product Movement Analysis
  • 4.2. Consumables
    • 4.2.1. Consumables Market, 2018 to 2030 (USD Million)
    • 4.2.2. Reagents, kits, media, and sera
      • 4.2.2.1. Reagents, kits, media, and sera Market, 2018 to 2030 (USD Million)
    • 4.2.3. Beads
      • 4.2.3.1. Beads Market, 2018 to 2030 (USD Million)
    • 4.2.4. Disposables
      • 4.2.4.1. Disposables Market, 2018 to 2030 (USD Million)
  • 4.3. Instruments
    • 4.3.1. Instruments Market, 2018 to 2030 (USD Million)
    • 4.3.2. Centrifuges
      • 4.3.2.1. Centrifuges Market, 2018 to 2030 (USD Million)
    • 4.3.3. Flow cytometers
      • 4.3.3.1. Flow cytometers Market, 2018 to 2030 (USD Million)
    • 4.3.4. Filtration systems
      • 4.3.4.1. Filtration systems Market, 2018 to 2030 (USD Million)
    • 4.3.5. Magnetic-activated cell separator systems
      • 4.3.5.1. Magnetic-activated cell separator systems Market, 2018 to 2030 (USD Million)

Chapter 5. Cell Type Business Analysis

  • 5.1. Cell Separation Market: Cell Type Movement Analysis
  • 5.2. Human Cells
    • 5.2.1. Human Cells Market, 2018 to 2030 (USD Million)
  • 5.3. Animal Cells
    • 5.3.1. Animal Cells Market, 2018 to 2030 (USD Million)

Chapter 6. Technique Business Analysis

  • 6.1. Cell Separation Market: Technique Movement Analysis
  • 6.2. Centrifugation
    • 6.2.1. Centrifugation Market, 2018 to 2030 (USD Million)
  • 6.3. Surface Marker
    • 6.3.1. Surface Marker Market, 2018 to 2030 (USD Million)
  • 6.4. Filtration
    • 6.4.1. Filtration Market, 2018 to 2030 (USD Million)

Chapter 7. Application Business Analysis

  • 7.1. Cell Separation Market: Application Movement Analysis
  • 7.2. Biomolecule Isolation
    • 7.2.1. Biomolecule isolation Market, 2018 to 2030 (USD Million)
  • 7.3. Cancer Research
    • 7.3.1. Cancer research Market, 2018 to 2030 (USD Million)
  • 7.4. Stem Cell Research
    • 7.4.1. Stem cell research Market, 2018 to 2030 (USD Million)
  • 7.5. Tissue Regeneration
    • 7.5.1. Tissue regeneration Market, 2018 to 2030 (USD Million)
  • 7.6. In vitro Diagnostics
    • 7.6.1. In vitro diagnostics Market, 2018 to 2030 (USD Million)
  • 7.7. Therapeutics
    • 7.7.1. Therapeutics Market, 2018 to 2030 (USD Million)

Chapter 8. End-use Business Analysis

  • 8.1. Cell Separation Market: End-Use Movement Analysis
  • 8.2. Research Laboratories and Institutes
    • 8.2.1. Research laboratories and institutes Market, 2018 to 2030 (USD Million)
  • 8.3. Hospitals and Diagnostic Laboratories
    • 8.3.1. Hospitals and diagnostic laboratories Market, 2018 to 2030 (USD Million)
  • 8.4. Cell Banks
    • 8.4.1. Cell banks Market, 2018 to 2030 (USD Million)
  • 8.5. Biotechnology and Biopharmaceutical Companies
    • 8.5.1. Biotechnology and biopharmaceutical companies Market, 2018 to 2030 (USD Million)

Chapter 9. Regional Business Analysis

  • 9.1. Cell Separation Market Share By Region, 2023 & 2030
    • 9.1.1. North America
      • 9.1.1.1. North America Market Size, & Forecasts and Trend Analysis, 2018 to 2030 (USD Million)
      • 9.1.1.2. U.S.
      • 9.1.1.2.1. Key Country Dynamics
      • 9.1.1.2.2. Target Disease Prevalence
      • 9.1.1.2.3. Competitive Scenario
      • 9.1.1.2.4. Regulatory Framework
      • 9.1.1.2.5. U.S. Cell Separation Market, 2018 to 2030 (USD Million)
      • 9.1.1.3. Canada
      • 9.1.1.3.1. Key Country Dynamics
      • 9.1.1.3.2. Target Disease Prevalence
      • 9.1.1.3.3. Competitive Scenario
      • 9.1.1.3.4. Regulatory Framework
      • 9.1.1.3.5. Canada Cell Separation Market, 2018 to 2030 (USD Million)
    • 9.1.2. EUROPE
      • 9.1.2.1. Europe Market Size, & Forecasts and Trend Analysis, 2018 to 2030 (USD Million)
      • 9.1.2.2. UK
      • 9.1.2.2.1. Key Country Dynamics
      • 9.1.2.2.2. Target Disease Prevalence
      • 9.1.2.2.3. Competitive Scenario
      • 9.1.2.2.4. Regulatory Framework
      • 9.1.2.2.5. UK Cell Separation Market, 2018 to 2030 (USD Million)
      • 9.1.2.3. Germany
      • 9.1.2.3.1. Key Country Dynamics
      • 9.1.2.3.2. Target Disease Prevalence
      • 9.1.2.3.3. Competitive Scenario
      • 9.1.2.3.4. Regulatory Framework
      • 9.1.2.3.5. Germany Cell Separation Market, 2018 to 2030 (USD Million)
      • 9.1.2.4. France
      • 9.1.2.4.1. Key Country Dynamics
      • 9.1.2.4.2. Target Disease Prevalence
      • 9.1.2.4.3. Competitive Scenario
      • 9.1.2.4.4. Regulatory Framework
      • 9.1.2.4.5. France Cell Separation Market, 2018 to 2030 (USD Million)
      • 9.1.2.5. Italy
      • 9.1.2.5.1. Key Country Dynamics
      • 9.1.2.5.2. Target Disease Prevalence
      • 9.1.2.5.3. Competitive Scenario
      • 9.1.2.5.4. Regulatory Framework
      • 9.1.2.5.5. Italy Cell Separation Market, 2018 to 2030 (USD Million)
      • 9.1.2.6. Spain
      • 9.1.2.6.1. Key Country Dynamics
      • 9.1.2.6.2. Target Disease Prevalence
      • 9.1.2.6.3. Competitive Scenario
      • 9.1.2.6.4. Regulatory Framework
      • 9.1.2.6.5. Spain Cell Separation Market, 2018 to 2030 (USD Million)
      • 9.1.2.7. Denmark
      • 9.1.2.7.1. Key Country Dynamics
      • 9.1.2.7.2. Target Disease Prevalence
      • 9.1.2.7.3. Competitive Scenario
      • 9.1.2.7.4. Regulatory Framework
      • 9.1.2.7.5. Denmark Cell Separation Market, 2018 to 2030 (USD Million)
      • 9.1.2.8. Sweden
      • 9.1.2.8.1. Key Country Dynamics
      • 9.1.2.8.2. Target Disease Prevalence
      • 9.1.2.8.3. Competitive Scenario
      • 9.1.2.8.4. Regulatory Framework
      • 9.1.2.8.5. Sweden Cell Separation Market, 2018 to 2030 (USD Million)
      • 9.1.2.9. Norway
      • 9.1.2.9.1. Key Country Dynamics
      • 9.1.2.9.2. Target Disease Prevalence
      • 9.1.2.9.3. Competitive Scenario
      • 9.1.2.9.4. Regulatory Framework
      • 9.1.2.9.5. Norway Cell Separation Market, 2018 to 2030 (USD Million)
    • 9.1.3. ASIA PACIFIC
      • 9.1.3.1. Asia Pacific Market Size, & Forecasts and Trend Analysis, 2018 to 2030 (USD Million)
      • 9.1.3.2. Japan
      • 9.1.3.2.1. Key Country Dynamics
      • 9.1.3.2.2. Target Disease Prevalence
      • 9.1.3.2.3. Competitive Scenario
      • 9.1.3.2.4. Regulatory Framework
      • 9.1.3.2.5. Japan Cell Separation Market, 2018 to 2030 (USD Million)
      • 9.1.3.3. China
      • 9.1.3.3.1. Key Country Dynamics
      • 9.1.3.3.2. Target Disease Prevalence
      • 9.1.3.3.3. Competitive Scenario
      • 9.1.3.3.4. Regulatory Framework
      • 9.1.3.3.5. China Cell Separation Market, 2018 to 2030 (USD Million)
      • 9.1.3.4. India
      • 9.1.3.4.1. Key Country Dynamics
      • 9.1.3.4.2. Target Disease Prevalence
      • 9.1.3.4.3. Competitive Scenario
      • 9.1.3.4.4. Regulatory Framework
      • 9.1.3.4.5. India Cell Separation Market, 2018 to 2030 (USD Million)
      • 9.1.3.5. South Korea
      • 9.1.3.5.1. Key Country Dynamics
      • 9.1.3.5.2. Target Disease Prevalence
      • 9.1.3.5.3. Competitive Scenario
      • 9.1.3.5.4. Regulatory Framework
      • 9.1.3.5.5. South Korea Cell Separation Market, 2018 to 2030 (USD Million)
      • 9.1.3.6. Australia
      • 9.1.3.6.1. Key Country Dynamics
      • 9.1.3.6.2. Target Disease Prevalence
      • 9.1.3.6.3. Competitive Scenario
      • 9.1.3.6.4. Regulatory Framework
      • 9.1.3.6.5. Australia Cell Separation Market, 2018 to 2030 (USD Million)
      • 9.1.3.7. Thailand
      • 9.1.3.7.1. Key Country Dynamics
      • 9.1.3.7.2. Target Disease Prevalence
      • 9.1.3.7.3. Competitive Scenario
      • 9.1.3.7.4. Regulatory Framework
      • 9.1.3.7.5. Thailand Cell Separation Market, 2018 to 2030 (USD Million)
    • 9.1.4. LATIN AMERICA
      • 9.1.4.1. Latin America Market Size, & Forecasts and Trend Analysis, 2018 to 2030 (USD Million)
      • 9.1.4.2. Brazil
      • 9.1.4.2.1. Key Country Dynamics
      • 9.1.4.2.2. Target Disease Prevalence
      • 9.1.4.2.3. Competitive Scenario
      • 9.1.4.2.4. Regulatory Framework
      • 9.1.4.2.5. Brazil Cell Separation Market, 2018 to 2030 (USD Million)
      • 9.1.4.3. Mexico
      • 9.1.4.3.1. Key Country Dynamics
      • 9.1.4.3.2. Target Disease Prevalence
      • 9.1.4.3.3. Competitive Scenario
      • 9.1.4.3.4. Regulatory Framework
      • 9.1.4.3.5. Mexico Cell Isolation/Separation, 2018 to 2030 (USD Million)
      • 9.1.4.4. Argentina
      • 9.1.4.4.1. Key Country Dynamics
      • 9.1.4.4.2. Target Disease Prevalence
      • 9.1.4.4.3. Competitive Scenario
      • 9.1.4.4.4. Regulatory Framework
      • 9.1.4.4.5. Argentina Cell Separation Market, 2018 to 2030 (USD Million)
    • 9.1.5. MIDDLE EAST & AFRICA
      • 9.1.5.1. Middle East & Africa Market Size, & Forecasts and Trend Analysis, 2018 to 2030 (USD Million)
      • 9.1.5.2. South Africa
      • 9.1.5.2.1. Key Country Dynamics
      • 9.1.5.2.2. Target Disease Prevalence
      • 9.1.5.2.3. Competitive Scenario
      • 9.1.5.2.4. Regulatory Framework
      • 9.1.5.2.5. South Africa Cell Separation Market, 2018 to 2030 (USD Million)
      • 9.1.5.3. Saudi Arabia
      • 9.1.5.3.1. Key Country Dynamics
      • 9.1.5.3.2. Target Disease Prevalence
      • 9.1.5.3.3. Competitive Scenario
      • 9.1.5.3.4. Regulatory Framework
      • 9.1.5.3.5. Saudi Arabia Cell Separation Market, 2018 to 2030 (USD Million)
      • 9.1.5.4. UAE
      • 9.1.5.4.1. Key Country Dynamics
      • 9.1.5.4.2. Target Disease Prevalence
      • 9.1.5.4.3. Competitive Scenario
      • 9.1.5.4.4. Regulatory Framework
      • 9.1.5.4.5. UAE Cell Separation Market, 2018 to 2030 (USD Million)
      • 9.1.5.5. Kuwait
      • 9.1.5.5.1. Key Country Dynamics
      • 9.1.5.5.2. Target Disease Prevalence
      • 9.1.5.5.3. Competitive Scenario
      • 9.1.5.5.4. Regulatory Framework
      • 9.1.5.5.5. Kuwait Cell Separation Market, 2018 to 2030 (USD Million)

Chapter 10. COMPANY PROFILES

  • 10.1. Company Profiles
    • 10.1.1. THERMO FISHER SCIENTIFIC, INC
      • 10.1.1.1. Company overview
      • 10.1.1.2. Financial Performance
      • 10.1.1.3. Product benchmarking
      • 10.1.1.4. Strategic initiatives
    • 10.1.2. MERCK KGAA
      • 10.1.2.1. Company overview
      • 10.1.2.2. Financial Performance
      • 10.1.2.3. Product benchmarking
      • 10.1.2.4. Strategic initiatives
    • 10.1.3. BD
      • 10.1.3.1. Company overview
      • 10.1.3.2. Financial Performance
      • 10.1.3.3. Product benchmarking
      • 10.1.3.4. Strategic initiatives
    • 10.1.4. TERUMO CORPORATION
      • 10.1.4.1. Company overview
      • 10.1.4.2. Financial Performance
      • 10.1.4.3. Product benchmarking
      • 10.1.4.4. Strategic initiatives
    • 10.1.5. DANAHER
      • 10.1.5.1. Company overview
      • 10.1.5.2. Financial Performance
      • 10.1.5.3. Product benchmarking
      • 10.1.5.4. Strategic initiatives
    • 10.1.6. STEMCELL TECHNOLOGIES INC.
      • 10.1.6.1. Company overview
      • 10.1.6.2. Financial Performance
      • 10.1.6.3. Product benchmarking
      • 10.1.6.4. Strategic initiatives
    • 10.1.7. BIO-RAD LABORATORIES, INC.
      • 10.1.7.1. Company overview
      • 10.1.7.2. Financial Performance
      • 10.1.7.3. Product benchmarking
      • 10.1.7.4. Strategic initiatives
    • 10.1.8. AGILENT TECHNOLOGIES, INC.,
      • 10.1.8.1. Company overview
      • 10.1.8.2. Financial Performance
      • 10.1.8.3. Product benchmarking
      • 10.1.8.4. Strategic initiatives
    • 10.1.9. CORNING INCORPORATED.
      • 10.1.9.1. Company overview
      • 10.1.9.2. Financial Performance
      • 10.1.9.3. Product benchmarking
      • 10.1.9.4. Strategic initiatives
    • 10.1.10. AKADEUM LIFE SCIENCES
      • 10.1.10.1. Company overview
      • 10.1.10.2. Financial Performance
      • 10.1.10.3. Product benchmarking
      • 10.1.10.4. Strategic initiatives
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제